Streetbeat News

Earnings

TDOC

Teladoc forecasts its FY24 earnings per share (EPS) to be between ($1.10) and ($0.80), which is an improvement over the estimated $(1.23). However, its revenue projection of $2.635B to $2.735B falls short of the estimated $2.77B.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:13 pm

TRUE

TrueCar (NASDAQ:TRUE) reported Q4 2023 earnings with a smaller loss per share of $(0.02) compared to the expected $(0.06), beating estimates by 66.67%. However, their sales of $41.29M fell short of the $41.86M estimate by 1.38%, despite being a 12.61% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:12 pm

TDOC

Teladoc forecasts its Q1 earnings per share (EPS) to be between ($0.55) and ($0.45), which is below the estimated $(0.43). The company also projects its revenue to be between $630M and $645M, falling short of the expected $672.87M.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:12 pm

ANDE

Andersons (NASDAQ:ANDE) reported Q4 2023 adjusted EPS of $1.59, surpassing the $0.99 estimate by 60.61%, but its sales of $3.21B fell short of the $4.26B estimate by 24.63%, marking a 31.30% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:11 pm

MATX

Matson (NYSE:MATX) reported Q4 2023 earnings of $1.78 per share, surpassing the $1.30 estimate by 36.92%. Quarterly sales reached $788.90M, exceeding the $733.60M estimate by 7.54%, yet marking a 1.58% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:11 pm

CZR

Caesars Entertainment (NASDAQ:CZR) reported Q4 earnings, beating estimates with an EPS of $0.1 against an expected -$0.04. Revenue increased by $4.00 million from the previous year. Despite beating last quarter's EPS estimate, the share price dropped by 1.05% the following day. Historical earnings data shows fluctuating performance over the past year.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:11 pm

CHK

Chesapeake Energy (NASDAQ:CHK) reported Q4 earnings with an EPS of $1.31, surpassing the estimate of $0.75 by 74.67%. However, revenue decreased by $2.18 billion from the same period last year. In the previous quarter, CHK beat the EPS estimate by $0.45, leading to a 0.96% increase in share price the following day. The company has shown a pattern of surpassing EPS estimates over the past four quarters.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:10 pm

THAR

Tharimmune Inc (NASDAQ:THAR) completed its Phase 1 clinical trial for TH104, a transmucosal buccal film for chronic liver disease, showing safety and tolerability comparable to FDA-approved nalmefene. The trial's full data is expected in Q2 2024. Last quarter, Tharimmune closed an $11 million public offering to extend its cash runway into early 2025 for TH104's clinical readouts. THAR shares rose 0.26% to $0.39.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 9:10 pm

WSC

WillScot Mobile Mini (NASDAQ:WSC) reported Q4 earnings with an EPS of $0.44, missing estimates by 15.38% against an expected $0.52. Revenue increased by $21.82 million from the previous year. The company's past earnings performance shows a mixed trend with occasional beats and misses. Last quarter, a slight beat in EPS was followed by an 8.77% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:10 pm

CWK

Cushman & Wakefield (NYSE:CWK) reported Q4 earnings with a 12.5% beat on EPS estimates, reporting $0.45 versus the expected $0.4. However, revenue was down $95 million from the same period last year. Despite missing EPS estimates last quarter, CWK's share price increased by 8.7% the following day. The company's past earnings performance shows mixed results with both misses and beats on EPS and revenue estimates.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:10 pm